Case Report

A New Case of Syringocystadenocarcinoma Papilliferum: A Rare Pathology for a Wide-Ranging Comprehension

Table 1

Histogenetic theories of syringocystadenocarcinoma papilliferum.

Source, yearEccrine and/or apocrine histogenesis

Dissanayake and Salm, 1980 [5]Eccrine: in situ carcinoma

Dissanayake and Salm, 1980 [5]Eccrine

Seco Navedo et al., 1982 [6]Apocrine

Numata et al., 1985 [7]Apocrine

Bondi and Urso, 1996 [8]Eccrine

Ishida-Yamamoto et al., 2001 [4]In situ carcinoma, near the anal apocrine glands, small number of tumor cells diastase-resistant, origin from a pluripotential germinative cell

Arai et al., 2003 [9]In situ carcinoma, diastase-resistant PAS-positive

Chi et al., 2004 [10]Either pluripotential appendageal cells or primitive apocrine glands

Woestenborghs et al., 2006 [11]Eccrine: in situ carcinoma

Kazakov et al., 2007 [12]In situ carcinoma arising in association with SCAP and sebaceous carcinoma

Park et al., 2007 [13]SCACP originates from apocrine glands

Langner and Ott, 2009 [14]In situ carcinoma, luminal columnar cells with decapitation secretion

Kazakov et al., 2010 [15]Apocrine: 5 new cases: in situ carcinoma and invasive tumors; squamous differentiation

Leeborg et al., 2010 [2]Apocrine: in situ carcinoma and invasive tumor; squamous differentiation

Sroa et al., 2010 [16]Eccrine

Aydin et al., 2011 [17]Eccrine

Hoekzema et al., 2011 [1]Apocrine: from pluripotent cells

Hoguet et al., 2012 [18]Apocrine

Zhang et al., 2012 [19]Apocrine with squamous differentiation

Present case, 2014Apocrine: from pluripotent cells by epithelial mesenchymal transition